Cayman Islands, July 31, 2025 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp. (NASDAQ: SLXN) (“Silexion Therapeutics” or the “Company”), a clinical-stage…
Abivax Announces Full Exercise of Underwriters’ Option to Purchase Additional ADSs, Bringing Gross Proceeds of Offering to $747.5M (€637.5M) PARIS,…
NEW HAVEN, Conn., July 11, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) has entered into an agreement…
Press release CROSSJECT announces a successful capital increase of €5.7 million following full exercise of the extension clause Transaction raised…
June 16, 2025 19:20 ET | Source: PolyPid Ltd. The Company Anticipates that with this Additional Funding, PolyPid’s Runway would…